Literature DB >> 9220013

Relating primary structure to function in the Escherichia coli XerD site-specific recombinase.

A J Spiers1, D J Sherratt.   

Abstract

XerC and XerD are related 298-amino-acid site-specific recombinases, each of which is responsible for the exchange of one pair of strands in Xer recombination. Both recombinases encode functions necessary for sequence-specific DNA-binding, co-operative XerC/D interactions, synapsis and catalysis. These functions were related to the primary amino acid sequence by constructing and analysing internal and C-terminal XerD deletions. An XerD derivative containing residues 1-233 was proficient in specific DNA binding, but did not interact co-operatively with XerC. Deletion of a further five C-terminal amino acids abolished binding to DNA. Proteins deleted for residues 32-88 and for residues 145-159 were deficient in DNA binding. Deletion of residues 244-281, a region containing amino acids necessary for catalysis, gave a protein that bound to DNA. An XerD derivative containing residues 1-268 retained co-operative interactions with XerC; nevertheless, it did not support XerC strand exchange and was defective in XerD catalysis. Residues 1-283 retain a functional catalytic active site, though a protein lacking the five C-terminal amino acids was still unable to mediate normal in vivo recombination, indicating that these residues are needed for a function that is not directly related to DNA binding or catalysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220013     DOI: 10.1046/j.1365-2958.1997.4171784.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  8 in total

1.  Small plasmids harboring qnrB19: a model for plasmid evolution mediated by site-specific recombination at oriT and Xer sites.

Authors:  Tung Tran; Patricia Andres; Alejandro Petroni; Alfonso Soler-Bistué; Ezequiel Albornoz; Angeles Zorreguieta; Rodrigo Reyes-Lamothe; David J Sherratt; Alejandra Corso; Marcelo E Tolmasky
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

2.  Similarities and differences among 105 members of the Int family of site-specific recombinases.

Authors:  S E Nunes-Düby; H J Kwon; R S Tirumalai; T Ellenberger; A Landy
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

3.  Crystal structure of the site-specific recombinase, XerD.

Authors:  H S Subramanya; L K Arciszewska; R A Baker; L E Bird; D J Sherratt; D B Wigley
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

4.  Differences in resolution of mwr-containing plasmid dimers mediated by the Klebsiella pneumoniae and Escherichia coli XerC recombinases: potential implications in dissemination of antibiotic resistance genes.

Authors:  Duyen Bui; Judianne Ramiscal; Sonia Trigueros; Jason S Newmark; Albert Do; David J Sherratt; Marcelo E Tolmasky
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

5.  Evidence for a Xer/dif system for chromosome resolution in archaea.

Authors:  Diego Cortez; Sophie Quevillon-Cheruel; Simonetta Gribaldo; Nicole Desnoues; Guennadi Sezonov; Patrick Forterre; Marie-Claude Serre
Journal:  PLoS Genet       Date:  2010-10-21       Impact factor: 5.917

6.  FtsK translocation on DNA stops at XerCD-dif.

Authors:  James E Graham; Viknesh Sivanathan; David J Sherratt; Lidia K Arciszewska
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

7.  Dissection of a functional interaction between the DNA translocase, FtsK, and the XerD recombinase.

Authors:  James Yates; Ivailo Zhekov; Rachel Baker; Bjørn Eklund; David J Sherratt; Lidia K Arciszewska
Journal:  Mol Microbiol       Date:  2006-03       Impact factor: 3.501

8.  Functional Analysis of the Acinetobacter baumannii XerC and XerD Site-Specific Recombinases: Potential Role in Dissemination of Resistance Genes.

Authors:  David L Lin; German M Traglia; Rachel Baker; David J Sherratt; Maria Soledad Ramirez; Marcelo E Tolmasky
Journal:  Antibiotics (Basel)       Date:  2020-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.